Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation
Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis lymphoma
Lymphoma
Evaluation of T lymphocytes and NK cells absolute number, 1 year
Evaluation of discrete T-cells populations, Evaluation, by flow cytometry, of discrete T cell populations, including CD4+ and CD8+ TN, TSCM, TCM and TEM, NK and NKT cells, B cells, dendritic cell subsets, 1 year|Evaluation of antigen-specific T cell populations, Evaluation of antigen-specific T cell frequency towards CMV, EBV and influenza virus by MHC tetramers, 1 year|Evaluation of antigen-specific T lymphocyte's functionality, antigen-specific T lymphocyte's functionality towards tumor cell line evaluated using a degranulation assay, 1 year|Evaluation of cytokines production by IL-2 and anti-CD16 activated NK cells, 1 year
Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis lymphoma